# Aliskiren in Patients With Idiopathic Membranous Nephropathy

> **NCT01093781** · NA · WITHDRAWN · sponsor: **Mayo Clinic**

## Conditions studied

- Idiopathic Membranous Nephropathy

## Interventions

- **DRUG:** Aliskiren

## Key facts

- **NCT ID:** NCT01093781
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2010-11
- **Primary completion:** 2011-12
- **Final completion:** 2011-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Manufacturer asked to close study due to AEs experienced by subjects in other studies.
- **Last updated:** 2013-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01093781

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01093781, "Aliskiren in Patients With Idiopathic Membranous Nephropathy". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT01093781. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*